Aurinia Pharmaceuticals Inc (AUPH)
5.04
-0.06
(-1.18%)
USD |
NASDAQ |
Apr 15, 16:00
5.045
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Price: 5.04 for April 15, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 15, 2024 | 5.09 | 5.226 | 5.02 | 5.04 | 1.337M |
| Apr 12, 2024 | 5.02 | 5.11 | 4.97 | 5.10 | 1.722M |
| Apr 11, 2024 | 5.02 | 5.11 | 4.97 | 5.08 | 855153.0 |
| Apr 10, 2024 | 4.99 | 5.06 | 4.95 | 4.99 | 1.652M |
| Apr 09, 2024 | 4.99 | 5.26 | 4.98 | 5.11 | 1.501M |
| Apr 08, 2024 | 5.05 | 5.05 | 4.97 | 4.98 | 831181.0 |
| Apr 05, 2024 | 5.07 | 5.16 | 5.01 | 5.05 | 1.053M |
| Apr 04, 2024 | 5.24 | 5.30 | 5.065 | 5.09 | 1.204M |
| Apr 03, 2024 | 5.04 | 5.20 | 5.00 | 5.18 | 1.185M |
| Apr 02, 2024 | 5.35 | 5.35 | 5.04 | 5.08 | 1.164M |
| Apr 01, 2024 | 5.00 | 5.41 | 4.97 | 5.40 | 2.477M |
| Mar 28, 2024 | 4.99 | 5.04 | 4.97 | 5.01 | 1.375M |
| Mar 27, 2024 | 4.95 | 5.015 | 4.85 | 5.00 | 1.439M |
| Mar 26, 2024 | 4.98 | 5.07 | 4.93 | 4.93 | 948678.0 |
| Mar 25, 2024 | 5.00 | 5.07 | 4.96 | 4.99 | 969097.0 |
| Mar 22, 2024 | 5.03 | 5.03 | 4.94 | 4.97 | 1.792M |
| Mar 21, 2024 | 5.20 | 5.25 | 5.00 | 5.01 | 1.871M |
| Mar 20, 2024 | 5.15 | 5.23 | 5.025 | 5.14 | 1.808M |
| Mar 19, 2024 | 5.05 | 5.19 | 4.96 | 5.18 | 1.177M |
| Mar 18, 2024 | 5.18 | 5.22 | 5.06 | 5.09 | 1.267M |
| Mar 15, 2024 | 5.07 | 5.20 | 5.06 | 5.17 | 2.205M |
| Mar 14, 2024 | 5.20 | 5.24 | 4.98 | 5.09 | 1.987M |
| Mar 13, 2024 | 5.16 | 5.29 | 5.16 | 5.25 | 1.349M |
| Mar 12, 2024 | 5.39 | 5.39 | 5.19 | 5.20 | 1.874M |
| Mar 11, 2024 | 5.40 | 5.56 | 5.345 | 5.37 | 1.469M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.88
Minimum
Oct 14 2019
33.08
Maximum
Oct 29 2021
11.81
Average
11.22
Median
Price Benchmarks
| Lexaria Bioscience Corp | 1.99 |
| Acasti Pharma Inc | 3.37 |
| Edesa Biotech Inc | 4.16 |
| Xenon Pharmaceuticals Inc | 41.35 |
| ESSA Pharma Inc | 7.30 |
Price Related Metrics
| PS Ratio | 4.106 |
| Price to Book Value | 1.928 |
| Earnings Yield | -10.52% |
| Market Cap | 728.87M |